BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY

Clinical trials for BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY explained in plain language.

Never miss a new study

Get alerted when new BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY trials appear

Sign up with your email to follow new studies for BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2

One-Time gene injection aims to halt rare blindness

Disease control Not yet recruiting

This trial tests a single injection of a gene therapy called ZVS101e for people with Bietti crystalline dystrophy, a rare inherited eye disease that leads to progressive vision loss. The therapy uses a harmless virus to deliver a working copy of the CYP4V2 gene to cells in the ey…

Matched conditions: BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY

Phase: NA • Sponsor: Chigenovo Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY

Get alerted when new BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY trials appear

One-Time gene injection aims to halt rare blindness